Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Hubert

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|September 7, 2017
Zika virus has oncolytic activity against glioblastoma stem cellsZhe Zhu, Matthew J Gorman, Lisa D McKenzie, et al.
The Journal of Experimental Medicine|September 17, 2017
Correction: Zika virus has oncolytic activity against glioblastoma stem cellsZhe Zhu, Matthew J Gorman, Lisa D McKenzie, et al.
Genes & Development|May 9, 2013
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5AChristopher G Hubert, Robert K Bradley, Yu Ding, et al.
Cancer Discovery|November 17, 2012
Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cellsYu Ding, Christopher G Hubert, Jacob Herman, et al.
Cancer Research|July 22, 2017
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating CellsXiuxing Wang, Zhi Huang, Qiulian Wu, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
Neuro-Oncology Advances|January 19, 2024
Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responsesKatie M Troike, Sabrina Z Wang, Daniel J Silver, et al.
Cancer Cell|October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsDavid L Schonberg, Tyler E Miller, Qiulian Wu, et al.
JCI Insight|May 5, 2026
Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastomaJesse A Coker, Steven R Martinez, Sang Hoon Han, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|September 7, 2017
Zika virus has oncolytic activity against glioblastoma stem cellsZhe Zhu, Matthew J Gorman, Lisa D McKenzie, et al.
The Journal of Experimental Medicine|September 17, 2017
Correction: Zika virus has oncolytic activity against glioblastoma stem cellsZhe Zhu, Matthew J Gorman, Lisa D McKenzie, et al.
Genes & Development|May 9, 2013
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5AChristopher G Hubert, Robert K Bradley, Yu Ding, et al.
Cancer Discovery|November 17, 2012
Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cellsYu Ding, Christopher G Hubert, Jacob Herman, et al.
Cancer Research|July 22, 2017
MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating CellsXiuxing Wang, Zhi Huang, Qiulian Wu, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
Neuro-Oncology Advances|January 19, 2024
Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responsesKatie M Troike, Sabrina Z Wang, Daniel J Silver, et al.
Cancer Cell|October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsDavid L Schonberg, Tyler E Miller, Qiulian Wu, et al.
JCI Insight|May 5, 2026
Development and characterization of triazole-based WDR5 inhibitors for the treatment of glioblastomaJesse A Coker, Steven R Martinez, Sang Hoon Han, et al.
Cancer Research|September 7, 2022
VRK1 Is a Synthetic-Lethal Target in VRK2-Deficient GlioblastomaJulie A Shields, Samuel R Meier, Madhavi Bandi, et al.
Pageof 4